Endothelial dysfunction and cardiac damage indicators in patients with β-thalassemia major under iron-chelation therapy
Therapeutic Advances in Hematology
Published online on February 10, 2026
Abstract
Therapeutic Advances in Hematology, Volume 17, January-December 2026.
Background:Patients with β-thalassemia major remain at risk for endothelial dysfunction and cardiac injury due to iron overload, oxidative stress, and chronic inflammation, even with iron-chelation therapy. Assessing vascular and cardiac serum biomarkers ...
Background:Patients with β-thalassemia major remain at risk for endothelial dysfunction and cardiac injury due to iron overload, oxidative stress, and chronic inflammation, even with iron-chelation therapy. Assessing vascular and cardiac serum biomarkers ...